Data and Safety Monitoring Board Training Program Application Open
The Data and Safety Monitoring Board training program is now open for applications, offering African health and research professionals an opportunity to strengthen clinical trial safety oversight across the continent. This Data and Safety Monitoring Board training program is an intensive 8-week course designed to expand Africa’s pool of qualified DSMB experts and support ethical, high-quality vaccine and clinical research.
Led by Africa CDC and jointly sponsored by CEPI and SPEAC, the program combines self-paced learning with live virtual sessions facilitated by global experts in vaccine safety and clinical trial monitoring.
What Is the Data and Safety Monitoring Board Training Program?
The Data and Safety Monitoring Board training program focuses on building capacity for independent safety oversight in clinical trials, especially vaccine trials. DSMBs play a critical role in protecting participants, ensuring ethical compliance, and supporting evidence-based decision-making during research studies.
Through this program, participants gain practical knowledge and real-world insight into DSMB operations, regulatory frameworks, and safety monitoring methodologies. As a result, graduates contribute directly to improved public health outcomes and global health preparedness.
Why the Data and Safety Monitoring Board Training Program Matters
Clinical trials require rigorous oversight to ensure participant safety and data integrity. Therefore, the Data and Safety Monitoring Board training program addresses a major gap by increasing the number of trained DSMB professionals in Africa.
Moreover, the program supports:
- Ethical oversight of vaccine and clinical trials
- Stronger research governance across African institutions
- Improved readiness for emerging and re-emerging health threats
By strengthening DSMB capacity, the program enhances trust in clinical research and supports global collaboration.
Structure of the Data and Safety Monitoring Board Training Program
The Data and Safety Monitoring Board training program runs for 8 weeks and follows a blended learning format that balances flexibility with expert engagement.
Learning Format
- Self-paced online learning modules
- Live virtual sessions with leading experts
- Practical applications, quizzes, and a final assessment
This approach allows participants to learn at their own pace while still benefiting from interactive discussions and expert guidance.
Training Course Outline
Participants in the Data and Safety Monitoring Board training program will cover the following key areas:
- Introduction to Clinical Trials and DSMBs
- Vaccine Clinical Trials and Safety Monitoring
- DSMB Roles and Decision-Making Processes
- Regulatory and Ethical Considerations
- Safety Monitoring and Risk Assessment
- Statistical Methods for DSMB Review
- DSMB Meetings and Case Discussions
- Practical Applications, Quizzes, and Final Assessment
Together, these modules provide a strong foundation for effective participation in DSMB activities.
Benefits of Completing the Data and Safety Monitoring Board Training Program
Upon successful completion of the Data and Safety Monitoring Board training program, participants may join the DSMB Pool. From there, they may be considered for future roles in clinical trial safety oversight.
In addition, participants benefit from:
- Enhanced professional credibility
- Specialized expertise in clinical trial safety
- Opportunities to contribute to high-impact research
- Networking with experts across Africa and beyond
Consequently, this program serves as both a learning opportunity and a career-advancing pathway.
Key Dates and Application Details
- Application Deadline: January 31, 2026
- Training Start Date: February 12, 2026
- Training Duration: 8 weeks
- Training Mode: Virtual (self-paced + live sessions)
🔗 Application Link:
https://tools.africacdc.org/africacdcrc/surveys/?s=KDMM98XRLNENFLEW
Applicants are encouraged to apply early, as spaces may be limited.
Who Should Apply?
The Data and Safety Monitoring Board training program is ideal for professionals involved in:
- Clinical research
- Public health
- Vaccine development
- Biostatistics
- Regulatory and ethical review
If you are committed to strengthening clinical trial safety and improving health outcomes in Africa, this program offers the right platform.